Parenteral Drug (India) share news and announcements

BSE: 524689Pharmaceuticals & Biotechnology

Trading suspended since 3 Feb 2025

Last traded ₹2.90 on 21 Aug 2023

Parenteral Drug (India) share news and announcements

782 announcements, routine notices left out, newest first. Page 3 of 16.

Mar 2022
- 1 Mar · Change in designation
  Change in designation of Chhaya Gupta as Independent Director of the company w.e.f. 01-Mar-2022 (opens in a new tab)
- 1 Mar · Results
  Details of Voting results of EGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly <a href="https://www.bseindia.com/stock-share-price/meetings/voting-results/524689 ....
- 1 Mar · Extra Ordinary Meeting
  Scrutinizer report of Extra Ordinary General Meeting held on 01-Mar-2022 (opens in a new tab)
- 1 Mar · Extra Ordinary Meeting
  Voting results of Extra Ordinary General Meeting held on 01-Mar-2022 (opens in a new tab)
- 1 Mar · Extra Ordinary Meeting
  Proceedings of Extra Ordinary General Meeting held on 01-Mar-2022 (opens in a new tab)
- 1 Mar · Meeting
  Parenteral Drugs (India) Limited hereby submits Summary Proceedings of Extra-Ordinary General Meeting of the Company held on 1st March, 2022 through Video Conferencing/Other Audio Visual means. (opens in a new tab)
- 1 Mar · Meeting
  Parenteral Drugs (India) Limited hereby submits Summary Proceedings of Extra-ordinary General Meeting held on 01st March, 2022 through Video Conferencing/Other Audio Visual Means. (opens in a new tab)
Feb 2022
- 18 Feb · Legal
  Exchange has sought clarification from Parenteral Drugs (India) Limited with respect to announcement dated 02-Feb-2022, regarding appointment of Director and Company secretary in the Board meeting held on February 02, 2022. On basis of above the Company is required to clarify following: 1. Date of appointment/cessation (as applicable) & term of appointment2. Brief profile (in case of appointment)3. Whether intimated in 24hrs4. Affirmationﾠthat the Director being appointed is not debarred from holding the office of director by virtue of any SEBI order or any other such authority. The response of the Company is awaited.
- 14 Feb · Results
  Financial results for the period ended December 31, 2021. (opens in a new tab)
- 14 Feb · Results
  Parenteral Drugs (India)Limited hereby submits the Unaudited Financial Results of the Company (on both Standalone and Consolidated basis) for the quarter ended 31st December, 2021 along .... (opens in a new tab)
- 14 Feb · Board meeting
  Outcome of Board meeting held on February 14, 2022. (opens in a new tab)
- 14 Feb · Board meeting
  Parenteral Drugs (India) Limited hereby submits the outcome of the Board Meeting held on 14.02.2022 inter-alia considered, approved and took on record the Quarterly Unaudited Financial .... (opens in a new tab)
- 5 Feb · Announcement under Regulation 30 (LODR)-Meeting Updates
  Parenteral Drugs (India)Limited hereby inform the Stock Exchange about the notice of the Extra Ordinary General Meeting sent to the Shareholders of the Company on 04th February, 2022. (opens in a new tab)
- 5 Feb · Meeting
  Notice of Extraordinary General Meeting to be held on March 01, 2022 (opens in a new tab)
- 4 Feb · Board meeting
  To consider and approve the Unaudited Financial Results for the period ended December 31, 2021 and other business matters (opens in a new tab)
- 4 Feb · Board meeting
  PARENTERAL DRUGS (INDIA) LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2022 ,inter alia, to consider and approve the Unaudited (Provisional) .... (opens in a new tab)
- 3 Feb · Meeting
  Notice of Extraordinary General Meeting to be held on March 01, 2022 (opens in a new tab)
- 3 Feb · Meeting
  Parenteral drugs (India) Limited hereby informed that due to some of the typographical error the cut-off date mentioned in the Extra Ordinary General Meeting Notice submitted to the Stock .... (opens in a new tab)
- 2 Feb · Meeting
  Notice of Extraordinary General Meeting to be held on March 01, 2022 (opens in a new tab)
- 2 Feb · Corporate action
  Register of Members & Share Transfer Books of the Company will remain closed from 25-Feb-2022 to 01-Mar-2022 for the purpose of Meeting. (opens in a new tab)
- 2 Feb · Meeting
  Parenteral Drugs (India) Limited hereby intimates regarding Extra ordinary General Meeting to be held on Tuesday, the 01st day of March, 2022 at 9:30 a.m. through video conferencing/ other .... (opens in a new tab)
- 2 Feb · Change in Company Secretary/Compliance Officer
  Appointment of Ms Pooja Choukse as Company Secretary/Compliance Officer of the Company w.e.f. from 01/02/2022. (opens in a new tab)
- 2 Feb · Corporate action
  Parenteral Drugs (India) Limited hereby informs that the Register of Members and Share Transfer Books will be closed from 25th February, 2022 to 01st March, 2022 (both days inclusive). (opens in a new tab)
- 2 Feb · Management
  Parenteral Drugs (India) Limited hereby Intimates pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 regarding appointment of Mrs. Chhaya .... (opens in a new tab)
- 2 Feb · Management
  Change in Director(s) of the company. (opens in a new tab)
- 2 Feb · Management
  Parenteral Drugs (India) Limited hereby intimates pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 regarding appointment of Ms. Pooja .... (opens in a new tab)
- 2 Feb · Board meeting
  Parenteral Drugs (India) Limited hereby informs the exchange that the Board inter-alia considered, approved and took on record the following agenda items in the board meeting: - Draft .... (opens in a new tab)
- 2 Feb · Board meeting
  Outcome of the Board meeting held on February 02, 2022. (opens in a new tab)
Jan 2022
- 29 Jan · Board meeting
  PARENTERAL DRUGS (INDIA) LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 02/02/2022 ,inter alia, to consider and approve The appointment .... (opens in a new tab)
- 29 Jan · Board meeting
  To consider appointment of Independent Director and to consider sale, lease or disposal of the whole or substantially the whole of the undertaking of the Company. (opens in a new tab)
- 21 Jan · Shareholding for the Period Ended December 31, 2021
  Shareholding Pattern for the Period Ended December 31, 2021. For more details, kindly Click ....
- 18 Jan · Statement Of Investor Complaints For The Quarter Ended December 2021
  No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 0 0 0
- 6 Jan · Updates
  'OTS'.Change in terms of One Time Loan Settlement Proposal (opens in a new tab)
- 6 Jan · Announcement Under Regulation 30 SEBI (LODR) Updates - OTS
  Parenteral Drugs (India) Limited submits Change in terms of One Time Loan Settlement Proposal (opens in a new tab)
- 1 Jan · Management
  Resignation of Ms Suruchi Maheshwari as Company Secretary & Compliance Officer of the company w.e.f. January 01, 2022. (opens in a new tab)
- 1 Jan · Management
  Parenteral Drugs (India) Limited hereby submits Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 regarding Resignation of Company .... (opens in a new tab)
Dec 2021
- 8 Dec
  Related Party Transactions (opens in a new tab)
- 8 Dec · Related Party Transaction For The Half Year End 30Th September,2021
  Parenteral Drugs (India) Limited hereby submits disclosures of related party transactions on consolidated basis pursuant to Regulation 23(9) of SEBI (Listing Obligations and Disclosure .... (opens in a new tab)
Nov 2021
Oct 2021
- 20 Oct · Shareholding for the Period Ended September 30, 2021
  Shareholding Pattern for the Period Ended September 30, 2021. For more details, kindly Click ....
- 16 Oct · Statement Of Investor Complaints For The Quarter Ended September 2021
  No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 0 0 0
Sep 2021
- 25 Sep · Results
  Details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly ....
- 25 Sep · Updates
  'Submission of Scrutinizer Report'relating to voting results for 37th Annual General Meeting held on 24th September,2021 (opens in a new tab)